Novel Circovirus in Blood from Intravenous Drug Users, Yunnan, China

Yanpeng Li(Xinjiang Medical University), Chiyu Zhang(Chinese Academy of Sciences), Le Cao(Huazhong University of Science and Technology), Yong‐Tang Zheng(Kunming Institute of Zoology), Feng‐Liang Liu(Kunming Institute of Zoology), Peng Zhang(Shanghai Public Health Clinical Center), Na Li(Shandong University of Technology), Ren‐Rong Tian(Kunming Institute of Zoology), Yingying Ma(Northeast Agricultural University), Ye Mei(Tongji University)
Emerging infectious diseases
April 18, 2023
10.3201/eid2905.221617
Cited by 18

Related Papers

SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse model
|Science|2021|449
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques
|Cell Research|2020|251
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
|Cell Research|2021|198
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models
|Cell Research|2020|120
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection
|Nature Communications|2023|99